US Sunscreen Faces Biggest Change in Decades
Summary
The U.S. Food and Drug Administration (FDA) is considering approving bemotrizinol, a new sunscreen ingredient used safely in other countries, to improve sunscreen protection for Americans. This change could be the biggest update in sunscreen rules in over 25 years and may help reduce skin cancer, which affects many Americans.Key Facts
- Bemotrizinol is a strong sunscreen ingredient that blocks both UVA and UVB rays.
- UVA rays can cause skin aging and increase skin cancer risk, while UVB rays mainly cause sunburn and skin cancer.
- Bemotrizinol is very stable in sunlight and helps keep sunscreen effective longer.
- It has been used safely in Europe, Asia, and Australia for years.
- Sunscreens with bemotrizinol can be lighter and less greasy, which may encourage people to use them more often.
- The FDA regulates sunscreen ingredients as over-the-counter drugs, which means stricter approval rules compared to cosmetics.
- Adding bemotrizinol could increase the variety of sunscreen products available to U.S. consumers.
- Skin cancer is the most common cancer in the United States, with about one in five Americans expected to develop it in their lifetime.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.